How Reliable Is AI for Sports Injury Prediction?

The useful question is not whether AI can find a statistical signal in sports injury data. It can. The harder question is whether that signal is reliable enough to change an athlete’s training, playing status, rehabilitation plan, or medical counseling. That is where the current evidence on AI in sports injury prediction and recovery becomes less promotional and more clinically uncomfortable.

The strongest recent synthesis is not dismissive. In a 2025 systematic review in the British Journal of Sports Medicine, Leckey and colleagues found that machine learning models for sports injury prediction reported AUC values from 0.57 to 0.95 across more than 38 studies, with tree-based methods such as Random Forest and XGBoost often performing best; tree-based models were the highest performers in 60% of studies reviewed.[1] That is enough to take seriously. It is not enough to hand a coach a red-light, yellow-light, green-light dashboard and pretend the clinical work is done.

What the best current reviews actually show

Leckey et al. is the central evidence because it looks across the field rather than celebrating one promising model. Its message is mixed in the way most clinically relevant evidence is mixed: there is a real research signal, but it is unstable once the study designs are examined closely. Only 3 studies exceeded an AUC of 0.9, while the broader reported range stretched from barely better than modest discrimination to apparently excellent performance.[1]

AUC is a ranking measure. It tells us how well a model separates athletes who later had the outcome from those who did not across possible thresholds. It does not, by itself, tell a clinician what to do on Monday morning. A model with a moderate AUC may still produce too many false alarms, miss too many injuries, or identify a risk period so broad that no practical training decision follows.

That last point deserves more attention than it usually gets. In 4 of 12 head-to-head comparisons reviewed by Leckey et al., logistic regression outperformed machine learning models.[1] That does not mean logistic regression is always better. It means the model class is not the central problem. If the cohort is small, the injury definition shifts, the outcome is rare, or the prediction window is vague, a more sophisticated algorithm may simply become a more sophisticated way to overfit.

Yuan et al.’s 2025 narrative review reinforces the same problem from a broader angle: the literature is methodologically heterogeneous, with differences in populations, injury definitions, model inputs, outcomes, and evaluation strategies making clean comparison difficult.[2] Souaifi et al.’s 2025 scoping review adds the biomechanical and wearable-sensor context, where richer movement and load data may improve future models but also widen the gap between what can be measured and what has been validated for clinical decision-making.[3]

Why tree-based models keep showing up

The repeated success of Random Forest and XGBoost is plausible. Many sports medicine datasets are tabular: age, sex, prior injury, strength measures, workload variables, screening results, GPS-derived metrics, or biomechanical features. Tree-based ensembles can handle nonlinear relationships and interactions without requiring the very large datasets that deep learning usually needs.

That makes them a sensible fit for the field, not a shortcut around validation. The median cohort size in Leckey et al. was 122 participants.[1] For deep learning, that is plainly thin. For tree-based models, it is still often thin, especially when the injury outcome is uncommon and the number of candidate predictors grows. Class imbalance is not an abstract statistical concern here; it is the difference between a model that learns injury risk and a model that learns the majority class with a few unstable exceptions.

Small cohorts also distort the clinician’s sense of precision. A team physician or athletic trainer does not need a model that performed well after tuning inside one dataset. They need to know whether it holds up in another squad, another season, another level of play, and another documentation culture. A model trained on one environment may learn the quirks of that environment: how injuries were reported, who entered workload data, which athletes completed screening, and which outcomes counted.

Prediction windows can make or break clinical usefulness

A sports injury risk label is not useful just because it is statistically associated with a later injury. The timing has to match a decision. If a model says an athlete is at increased risk sometime this season, the clinician still has to decide whether to reduce today’s training load, alter next week’s progression, request imaging, modify return-to-play criteria, or simply monitor. Those are different decisions with different costs.

Leckey et al. specifically noted that clinical relevance was often undermined by prediction windows too broad to inform individual care decisions.[1] That is a translation problem, not a cosmetic limitation. A broad window may be acceptable for population surveillance or resource planning. It is much weaker when the output is attached to an identifiable athlete who may lose training exposure, playing time, selection opportunity, or trust in the medical staff.

The practical threshold is simple: the model’s time horizon should correspond to an action that someone is prepared to take. A 7-day neuromuscular load adjustment, a 2-week return-to-running progression, and a season-long preseason counseling discussion are not interchangeable. Combining them under the same phrase, “injury prediction,” hides the most important clinical distinction.

Screening data alone rarely carry the whole burden

Preseason screening has an appealing rhythm. Measure everyone, classify risk, intervene early. It is orderly, billable, and easy to explain. It also has a long history of promising more than it can deliver. Leckey et al. reported that 47–53% of studies used screening data alone for machine learning training when considered against the Bahr 2016 threshold for useful injury prediction.[1]

The problem is not that screening data are useless. Prior injury, strength asymmetry, range of motion, movement quality, and baseline capacity can matter. The problem is that injury risk changes after the screening day. Training load changes. Sleep changes. Selection pressure changes. A player compensates for soreness. A runner adds hills. A service member carries a different load. A model trained only on static screening variables may miss the dynamic exposure that actually moves risk.

Wearables and biomechanical sensors are the obvious next step, and Souaifi et al. describe the growing interest in integrating biomechanical data into injury prediction work.[3] That direction is promising, especially for repeatable signals that humans do not track well across sessions. But more data streams do not automatically fix weak outcome definitions, missing data, inconsistent exposure capture, or inadequate validation. Sensors can make a model richer; they can also make its failure harder to audit.

The external validation gap is the decisive one

Internal validation asks whether the model can perform on held-out or resampled data from the same underlying study environment. External validation asks whether it works somewhere else. For clinical adoption, the second question matters more. A risk score that collapses outside its development dataset is not a clinical tool; it is a local research finding.

The current sports injury prediction literature has very little external validation. That absence is not a technical footnote. It means clinicians cannot know whether a model’s performance reflects a generalizable injury signal or the local habits of data collection, athlete selection, injury reporting, and model development.

The University of Virginia 2026 validation example discussed in Why AI in Sports Injury Prevention Still Lacks Validation is a useful reality check: several military-deployed AI prediction systems performed poorly when tested in large cohorts. The point is not that military populations perfectly represent elite sport, youth sport, or recreational athletes. The point is that models that look plausible in development can become much less persuasive when they meet larger, less forgiving validation conditions.

That is the stage at which clinical responsibility becomes concrete. If a model labels an athlete high risk and the staff reduces training, someone must explain the lost opportunity. If the model labels an athlete low risk and the athlete is injured, someone must explain why the warning was absent or ignored. External validation does not remove those burdens, but without it the burden rests on evidence that has not earned the weight.

Explainability helps, but it is not a rescue device

Only 18% of studies reviewed by Leckey et al. applied model explainability methods such as SHAP or LIME.[1] That low rate matters because clinicians need more than a score. They need to know which variables drove the estimate, whether those variables are clinically plausible, and whether the model is relying on artifacts of collection rather than meaningful risk factors.

Still, explainability is often oversold. A SHAP plot can show which features influenced a prediction; it cannot prove that changing those features will reduce injury risk. If recent workload, prior injury, or a strength measure pushes the model upward, the clinical team still has to decide whether the feature is modifiable, whether the intervention is safe, and whether the predicted time window justifies action.

Explainability is most useful when it sits inside a stronger translation pathway: consistent injury definitions, reliable data capture, prespecified modeling choices, external validation, and a decision threshold tied to an actual intervention. Used alone, it can make an unstable model feel more understandable without making it more trustworthy.

Recovery prediction is related, but not the same problem

The phrase “AI in sports injury prediction and recovery” often blends two different clinical tasks. Predicting first injury or reinjury risk before the event is one task. Estimating rehabilitation progression, return-to-sport timing, or recovery trajectory after injury is another. The inputs, outcomes, and acceptable errors differ.

For broader context on current uses of AI across diagnosis and rehabilitation, see How AI Is Being Used in Sports Injury Diagnosis and Recovery. For the rehabilitation-specific evidence base, What the Evidence Says About AI in Sports Injury Rehabilitation is the more direct companion. Return-to-sport timeline prediction has its own evidence problem, covered separately in Can Machine Learning Predict Return-to-Sport Recovery Timelines?.

The distinction matters because a recovery model may be used to guide staged progression, identify delayed recovery, or support shared planning. A pre-injury model may alter exposure before anything has happened. Both can affect care, but the ethical and operational stakes are not identical.

Regulatory readiness cannot be inferred from these reviews

The evidence summarized here does not establish that AI sports injury prediction tools are cleared, approved, or ready for regulated clinical deployment. No systematic search was performed for FDA-cleared or CE-marked AI sports injury prediction devices specifically. Regulatory status would need product-level verification, not inference from general AI/ML medical device pathways.

That limitation is especially important for teams, clinics, universities, and military or occupational settings evaluating commercial tools. Vendor demonstrations may show attractive dashboards, and internal validation may sound reassuring. Neither substitutes for transparent external validation in the population where the tool will be used.

A similar diagnostic-therapeutic divide appears in other parts of medicine. AI can improve detection, triage, or workflow without necessarily improving downstream outcomes; the stroke-care parallel is discussed in Why AI in Stroke Care Boosts Workflow but Not Outcomes. Injury prediction has the same problem in a sports medicine shape: discrimination is not the same as a safer athlete.

What would make an injury prediction model clinically harder to dismiss

The bar is not perfection. Clinicians already make decisions under uncertainty. The bar is whether the model improves the decision compared with usual care, and whether its errors are understood before it changes someone’s training or medical plan.

• A prespecified injury definition that is consistent across development and validation cohorts.
• A prediction window tied to a real decision, such as short-term load modification or a defined return-to-sport checkpoint.
• External validation in a cohort that differs meaningfully from the development dataset.
• Transparent handling of class imbalance, missing data, and candidate predictors.
• Calibration and threshold analysis, not AUC alone.
• An explanation of which input data are realistically available in day-to-day sports medicine settings.

This practical point is not minor. A model that requires pristine daily sensor streams, complete athlete-reported outcomes, standardized strength testing, and perfectly coded injuries may be feasible in a research environment and brittle in a training room. If data entry falls to an athletic trainer already managing treatment, communication, documentation, and practice coverage, missingness is not a nuisance variable. It is part of the intervention.

The best future models may well combine screening, workload, biomechanical, and recovery data. Tree-based ensembles may continue to perform well, and wearable integration may expose useful patterns that clinicians cannot see reliably by observation alone. But the current literature supports research development more strongly than routine clinical adoption.

For now, AI-based injury prediction should be treated as an investigational decision-support approach: scientifically active, sometimes moderately accurate, and worth improving, but not ready to replace clinical judgment or independently determine athlete management. Before a risk score deserves that authority, it needs stable definitions, larger cohorts, external validation, and a time horizon that tells someone what to do next.

References

1. Leckey et al. systematic review on machine learning for sports injury prediction, British Journal of Sports Medicine, 2025.
2. Yuan et al. narrative review on machine learning and sports injury prediction, PMC, 2025.
3. Souaifi et al. scoping review on biomechanical and wearable approaches to sports injury prediction, Bioengineering, 2025.